Summary & Overview
HCPCS G9559: Documentation of Not Prescribing Beta-Lactam Antibiotic
HCPCS Level II code G9559 captures documentation that a beta-lactam antibiotic was not prescribed for medical reasons such as allergy or intolerance. Nationally, clear documentation of antibiotic contraindications is important for patient safety, antimicrobial stewardship, and accurate claims processing. Use of G9559 signals that a clinician assessed beta-lactam therapy and recorded a medically justified reason for avoidance.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical purpose, suggested service contexts, and the payer landscape covered. The publication outlines common billing modifiers associated with this service, typical sites where the code is used, and how G9559 fits into documentation workflows.
This summary provides benchmarks and policy-relevant context for billing teams and clinicians: what G9559 represents in medical records, why accurate documentation matters for patient safety and claims clarity, and where to look for additional code relationships and coding guidance. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code G9559 documents the medical reason(s) for not prescribing a beta-lactam antibiotic, such as a documented allergy or intolerance to beta-lactam agents. This code represents clinical documentation that a beta-lactam was considered but not prescribed for a patient due to medically justified reasons.
-
Service type: Documentation of clinical decision-making regarding antibiotic selection and contraindication reporting
-
Typical site of service: Ambulatory care settings, urgent care clinics, emergency departments, and outpatient primary care where antibiotic prescribing decisions are made
Clinical & Coding Specifications
Clinical Context
A patient presents to an outpatient primary care clinic or urgent care with a bacterial infection (for example, community-acquired pneumonia, urinary tract infection, or skin and soft tissue infection) and has a documented history of adverse reactions to beta-lactam antibiotics. The clinician performs a focused evaluation of the reported reaction (timing, symptoms, severity, prior exposure, and treatment required), reviews prior records and allergy testing if available, and documents a medical reason for not prescribing beta-lactam therapy. Documentation includes the specific adverse reaction (e.g., anaphylaxis, urticarial rash, severe delayed hypersensitivity), rationale for selecting an alternative non–beta-lactam agent, and any relevant allergy testing results or referral plans (such as referral for formal allergy/immunology evaluation or penicillin skin testing). Typical workflow steps: review patient history, interview regarding the documented allergy, examine prior records and lab/testing results, determine whether a beta-lactam contraindication exists, select an alternative antibiotic when indicated, and record the medical justification in the chart to support prescribing and billing of G9559. Typical sites of service include outpatient clinic, urgent care center, and emergency department for initial evaluation and documentation. Typical patient scenario: an adult with presumed streptococcal pharyngitis and a history of immediate urticarial reaction to amoxicillin; clinician documents the anaphylactic-type reaction and prescribes a macrolide, recording the medical reason for not prescribing a beta-lactam using G9559 in the chart and claim.
Coding Specifications
- The following modifiers are the most clinically relevant to billing and reporting when
G9559is used. Use the modifier that accurately reflects the service circumstances.